Westlake Chemical Partners LP
NYSE:WLKPChemicals
-$0.07 today
- Market cap
- $743.49M
- Beta
- 0.50
- P/E (TTM)
- 6.3
- EPS (TTM)
- $3.60
- Dividend yield
- 8.31%
Volume 0.01M
Average 0.03M
WLKP Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Westlake Chemical Partners LPNYSE: WLKP
Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026
Capital expenditures dips below year-ago levels
Q1 FY2026 capital expenditures of $5.56M (cash outflow) fell 65.2% year over year, behind the +24.0% change in trailing-twelve-month capital expenditures. Sequentially, it fell 37.1% from the prior quarter. Over 3 fiscal years it compounded at +13.4% a year.
Context
- Capital expenditures amounted to 6.8% of revenue in FY2025, up 2.4 pp from a year earlier.
- Capital expenditures grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -65.2% toward the trailing-twelve-month pace of +24.0%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (78.82M) USD
- Year-over-year change
- -60.9%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (78.82M) | -60.9% |
| FY2024 | 2024-12-31 | (48.97M) | -4.6% |
| FY2023 | 2023-12-31 | (46.82M) | +13.5% |
| FY2022 | 2022-12-31 | (54.12M) | +33.3% |
| FY2021 | 2021-12-31 | (81.17M) | — |
Capital Expenditures vs competitors
How WLKP compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +24.0% is the 2nd highest of 10, against a peer median of -11.5%.
- Capital expenditures amounts to 5.5% of revenue for WLKP, versus a peer median of 5.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $298M USD | -26.2% | -90.7% | 10.2% | |
| LTM Mar 2026 | $118.32M USD | -10.6% | +9.2% | 7.6% | |
| LTM Mar 2026 | PEN 95.17M PEN | +5.2% | -18.4% | 4.4% | |
| LTM Mar 2026 | $68.42M USD | +24.0% | +13.4% | 5.5% | |
| LTM Mar 2026 | $41.1M USD | +11.7% | -12.1% | 2.2% | |
| LTM Apr 2026 | $29M USD | -11.5% | +12.6% | 5.9% | |
| LTM Mar 2026 | $26.94M USD | -70.1% | -44.0% | 1.4% | |
| LTM Mar 2026 | $3.89M USD | +104.1% | +19.1% | 0.6% | |
| LTM Mar 2026 | $882.81K USD | -68.1% | -5.3% | 363.1% | |
LARLithium Argentina AG | LTM Mar 2026 | $200K USD | -78.3% | -97.4% | — |
| Peer median (excluding WLKP) | — | -11.5% | -12.1% | 5.1% | |
Competitors are the stored peer set for WLKP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 401.39M | 334.83M | 54.28M | 369.16M | 298.58M |
| Depreciation & Amortization | 108.81M | 121.07M | 110.2M | 111.9M | 127.98M |
| Deferred Income Tax | (436K) | (471.21M) | 0 | 0 | 0 |
| Stock-Based Compensation | 436K | 282K | 349K | 0 | 0 |
| Change in Working Capital | (105.68M) | 7.83M | 2.26M | 1.78M | (148.83M) |
| Accounts Receivables | (26.29M) | (14.44M) | 28.66M | 32.96M | (29.56M) |
| Inventory | (5.42M) | 4.18M | 283K | 374K | 1.29M |
| Accounts Payables | 19.78M | (17M) | 1.57M | (2.69M) | (2.35M) |
| Other Working Capital | (93.75M) | 35.09M | (28.25M) | (28.86M) | (118.21M) |
| Other Non-Cash Items | 3.92M | 470.92M | 284.9M | 2.16M | 2.74M |
| Operating Cash Flow | 408.44M | 463.74M | 452M | 485M | 280.47M |
| Capital Expenditures | (81.17M) | (54.12M) | (46.82M) | (48.97M) | (78.82M) |
| Acquisitions (Net) | 0 | 319.88M | 0 | 0 | 0 |
| Purchases of Investments | (276M) | (319.88M) | (174.12M) | (40M) | (10M) |
| Sales of Investments | 293M | 362M | 145M | 0 | 120M |
| Other Investing Activities | (130K) | (319.88M) | 0 | 0 | 0 |
| Investing Cash Flow | (64.3M) | (12M) | (75.94M) | (88.97M) | 31.18M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (66.38M) | (66.41M) | (66.42M) | (66.44M) | (66.45M) |
| Other Financing Activities | (277.86M) | (337.6M) | (315.81M) | (329.9M) | (259.25M) |
| Financing Cash Flow | (344.24M) | (404.01M) | (382.23M) | (396.33M) | (325.7M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (97K) | 47.73M | (6.16M) | (303K) | (14.05M) |
| Free Cash Flow | 327.27M | 409.62M | 405.18M | 436.03M | 201.65M |
Westlake Chemical Partners LP
NYSE:WLKP
Intrinsic Alpha fair value
Locked
Current Price
$21.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.